Q2 saw 8% revenue growth, strong segment performance, and a $1B Pentagon investment accelerating missile capacity. Full-year guidance was raised for both revenue and EPS, with a robust backlog and international sales up 20%. Missile Solutions IPO delayed to mid-2027 due to market conditions.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.